Alzheimers and 2nd gen antipsychotics Flashcards

1
Q

How does chlorpromazine work and what are the side effects

A

a. D2 receptor antagonist
b. Anticholinergic side effects such as sedation
c. Extra pyramidal side effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q
  1. How does haloperidol work and what are the side effects
A

a. V potent d2 antagonist
b. Takes 6-8 weeks for therapeutic effects
c. Little impact on negative symptoms
d. Extra pyramidal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q
  1. What are the second generation antipsychotics
A

a. Clozapine
b. Risperidone
c. Quetiapine
Aripiprazole

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q
  1. How does clozapine work and what are the side effects
A

a. Potent antagonists of 5-HT2A receptors
b. Efficacy in resistant schizophrenia and negative symptoms
Neutropenia, agranulocytosis, myocarditis and weight gain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How does risperidone work and what are the side effects

A

a. Potent antagonists of 5-HT2A and D2 receptors

b. More EPS and hyperprolactinaemia than other atypical antipsychotics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q
  1. How does quetiapine work and what are the side effects
A

a. Potent antagonist of H1 receptors

b. Lower incidence of EPS than others

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How does aripiprazole work and what are the side effect

A

a. Partial agonist of D2 and 5-HT1A receptors
b. No more efficacious than others
c. Reduced hyperprolactinaemia and weight gain than other antipsychotics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q
  1. What is the amyloid normal physiological processing
A

a. Usually APP is cleaved by alpha secretase
b. sAPPalpha released -> C83 fragment remains
c. C83 -> digested by gamma secretase
d. Products removed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q
  1. What is the pathophysiological processing of amyloid
A

a. APP cleaved by beta secretase
b. sAPPbeta release -> C99 fragment remains
c. C99 digested by gamma secretase releasing beta amyloid protein
d. Beta amyloid protein forms toxic aggregates (plaques)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q
  1. What is the physiology of tau
A

a. Soluble protein present in axons

b. Important for assembly and stability of microtubules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q
  1. What is the pathophysiology of tau
A

a. Hyperphosphorylated tau is insoluble -> self aggregates to form neurofibrillary tangles
b. Neurotoxic
c. Results in microtubule instability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the inflammation hypothesis

A

a. Microglia inc release of inflammatory mediators and cytotoxic proteins, inc phagocytosis, dec levels of neuroprotective proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q
  1. What are the clinical symptoms of Alzheimer’s
A

a. Memory loss- esp of recently acquired information
b. Disorientation/confusion
c. Language problems
d. Personality changes
Poor judgement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q
  1. What are the risk factors for Alzheimer’s
A

a. Age
b. Genetics
a. Amyloid precursor protein -> early onset
b. ApoE -> late onset

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q
  1. What drugs are used to treat alzheimers
A

a. Anticholinesterases

b. NMDA receptor blocker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What anticholinesterases are used and how do they act

A

a. Donepezil
a. Reversible cholinesterase inhibitor
b. Long plasma half life
b. Rivastigmine
a. Pseudo-reversible AchE & BChE inhibitor
b. 8 hour half life
c. Also available as a patch
c. Galantamine
a. Reversible cholinesterase inhibitor which is also an alpha 7 nicotinic receptor agonist

17
Q
  1. What is an example of an NMDA receptor blocker and how does it work
A

a. Memantine
b. Use dependent non-competitive NMDA receptor blocker with low channel affinity
a. More activated NMDA is, more effective the drug is
c. Only used in moderate-severe